> What if racemic ketamine performs better than esketamine? We'll never know because they won't test that. It's quite likely some public institutions (e.g., universities, public research labs, etc.) or other countries…
> Pharma companies don't benefit from getting Ketamine approved (since it's no longer patent protected), so no one is putting it through FDA for depression. This is incorrect. There are ongoing phase 3 clinical trials…
> What if racemic ketamine performs better than esketamine? We'll never know because they won't test that. It's quite likely some public institutions (e.g., universities, public research labs, etc.) or other countries…
> Pharma companies don't benefit from getting Ketamine approved (since it's no longer patent protected), so no one is putting it through FDA for depression. This is incorrect. There are ongoing phase 3 clinical trials…